Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9417123 | 0.75 | MEN1 (0.42) | MEN1CYP1A2KMT2ALPAR3LPAR1 | |
| SCHEMBL9142433 | 0.75 | MEN1 (0.42) | MEN1CYP1A2KMT2AFDPS | |
| SCHEMBL9340203 | 0.71 | FDPS (0.35) | FDPS | |
| Phosphoric Acid SCHEMBL2580447 | 0.68 | LAP3 (0.39) | FDPS | |
| SCHEMBL6355943 | 0.68 | CYP1A2 (0.72) | MEN1CYP1A2KMT2ALPAR3LPAR1 | |
| Phosphoric Acid SCHEMBL574558 | 0.65 | FDPS (0.43) | FDPS | |
| Phosphoric Acid SCHEMBL574780 | 0.65 | FDPS (0.43) | FDPS | |
| SCHEMBL1486019 | 0.65 | — | — | |
| SCHEMBL10343815 | 0.63 | FDPS (0.46) | LPAR3LPAR1LPAR2CYP3A4FDPS | |
| SCHEMBL10804132 | 0.63 | TSHR (0.39) | MEN1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5064819-A | Antidepressants, anxiolytic agents, GABA antagonists | CIBA-GEIGY CORPORATION (US) | 1991-11-12 | — | — | US | disclosed |